Re: F & A base for industry-sponsored trials Dolce, Peter J 21 Jan 2003 15:28 EST
Thanks -----Original Message----- From: Schoen, Alexander [mailto:xxxxxx@WINTHROP.ORG] Sent: Tuesday, January 21, 2003 2:31 PM To: xxxxxx@HRINET.ORG Subject: Re: [RESADM-L] F & A base for industry-sponsored trials It is allowed to charge F & A up to the amount of your DHHS Negotiated Rate, but since most of those rates are 50% and up, they will never be paid by industry sponsors. The rates of 20 - 30 % are usually based upon what the industry will reimburse. Most sponsors will allow 25%, some rare ones 30%. These rates probably don't fully cover the overhead involved in the clinical trials. ----------------------------------------- Alexander Schoen Director, Office of Sponsored Programs Winthrop-University Hospital 259 First Street Mineola, NY 11501 Phone: (516) 663-8997 Fax: (516) 663-9718 xxxxxx@winthrop.org -----Original Message----- From: Dolce, Peter J [mailto:xxxxxx@MAIL.MMC.EDU] Sent: Tuesday, January 21, 2003 2:18 PM To: xxxxxx@HRINET.ORG Subject: [RESADM-L] F & A base for industry-sponsored trials Most schools that conduct insudsty sponsored clinical trials charge F & A costs at 20-30%. What base do you use for this calculation? Peter J. Dolce, Ph.D. Director, Office of Research Support Services Meharry Medical College 1005 D. B. Todd Boulevard Nashville, TN 37203 Phone 615 327 6703 Fax 615 327 6716 This e-mail and any files transmitted with it may contain information that is PRIVILEGED, CONFIDENTIAL, and exempt from disclosure under applicable law. It is intended only for the individual(s) or entity named above. If you are not an intended recipient of this e-mail, you are hereby notified that any unauthorized use, dissemination or copying of this e-mail or the information contained in it or attached to it is strictly prohibited. If you have received this e-mail in error, please delete it and immediately notify the person named above by reply e-mail. Thank you. ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== This e-mail and any files transmitted with it may contain information that is PRIVILEGED, CONFIDENTIAL, and exempt from disclosure under applicable law. It is intended only for the individual(s) or entity named above. If you are not an intended recipient of this e-mail, you are hereby notified that any unauthorized use, dissemination or copying of this e-mail or the information contained in it or attached to it is strictly prohibited. If you have received this e-mail in error, please delete it and immediately notify the person named above by reply e-mail. Thank you. ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================